From Wikipedia, the free encyclopedia
Jump to: navigation, search

Peptech Limited used to be an Australian biotechnology company listed on the Australian Stock Exchange (ASX). Peptech described its operations as " ASX-listed Australian biotechnology company dedicated to developing and providing antibody and peptide-based human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals." [1] The company changed its name to Arana Therapeutics in November 2007 and was subject of a successful takeover bid by Cephalon at the end of 2009.

See also[edit]

External links[edit]